Orthofix Medical Inc.
OFIX
$9.93
$0.060.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 58.06% | 26.83% | -0.08% | -2.67% | -13.12% |
| Total Depreciation and Amortization | -45.06% | -44.71% | -17.35% | 22.67% | 19.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.84% | 10.47% | 24.46% | 11.68% | 27.90% |
| Change in Net Operating Assets | -6.49% | -11.67% | 57.41% | 47.24% | 63.70% |
| Cash from Operations | 31.29% | 29.30% | 734.01% | 281.00% | 185.71% |
| Capital Expenditure | -25.19% | 0.72% | 24.40% | 52.03% | 49.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -97.63% | -99.62% | 517.14% | 842.13% | 2,246.96% |
| Cash from Investing | -63.66% | -25.45% | 40.09% | 64.07% | 61.61% |
| Total Debt Issued | -59.38% | -- | 9.07% | -3.61% | -7.02% |
| Total Debt Repaid | 99.53% | 99.47% | -35.43% | -35.44% | -35.45% |
| Issuance of Common Stock | -6.76% | -5.24% | -0.41% | 3.01% | 23.00% |
| Repurchase of Common Stock | 87.60% | 91.87% | 91.13% | 66.11% | 18.35% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -40.00% | -19.24% | -22.02% | 39.13% | 26.69% |
| Cash from Financing | 123.16% | -101.55% | -36.35% | -52.43% | -59.59% |
| Foreign Exchange rate Adjustments | 616.15% | 250.75% | 5.57% | 788.11% | -241.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.96% | -101.30% | 3,111.00% | 555.59% | 251.14% |